<DOC>
	<DOCNO>NCT03016845</DOCNO>
	<brief_summary>Optimal understand ciprofloxacin pharmacokinetics critically ill patient lack result large variation achieve exposure possible inadequate therapy . The investigator hypothesize drug dose base CKD-EPIcr-cys provide useful method individualize optimize therapy ciprofloxacin eventually improve outcome . In multi-centre , observational , open-label study investigator aim define : model estimation renal function accurately predict ciprofloxacin clearance critically ill patient .</brief_summary>
	<brief_title>Pharmacokinetics Ciprofloxacin Critically Ill Patients</brief_title>
	<detailed_description>Correct estimation glomerular filtration rate ( GFR ) necessary critically ill patient order asses renal function . GFR subsequently use derive appropriate drug dose renally excrete drug warrant adequate dose adaptation . It known estimation GFR base creatinine clearance precise , especially population alter muscle mass instable renal function , Intensive Care Unit ( ICU ) population . The use combine filtration marker together , cystatin C creatinine , improve precision estimate GFR ( eGFR ) . Studies confirm eGFR base creatinine cystatin C precise eGFR creatinine eGFR cystatin C. The equation base creatinine cystatin C , Chronic Kidney Disease Epidemiology Collaboration creatinine-cystatin C ( CKD-EPIcr-cys ) , may therefore improve eGFR thus drug dose ICU patient , population reach PK/PD target frequently . So far little known drug dose base CKD-EPIcr-cys . Currently optimal understand ciprofloxacin pharmacokinetics critically ill patient lack , result large variation achieve exposure possible inadequate therapy . The investigator hypothesize drug dose base CKD-EPIcr-cys provide useful method individualize optimize therapy ciprofloxacin eventually improve outcome . In multi-centre , observational , open-label study investigator aim define model estimation renal function accurately predict ciprofloxacin clearance critically ill patient .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>1 . Patient admit ICU 2 . Subject least 18 year day first dose 3 . Is manage arterial line central venous catheter 4 . Is manage urinary catheter 5 . Is already treat ciprofloxacin part routine clinical care 1 . Has previously participate study 2 . Is renal replacement therapy ( RRT )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ciprofloxacin</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Intensive Care Unit</keyword>
	<keyword>Cystatin C</keyword>
	<keyword>CKD-EPI</keyword>
	<keyword>renal function</keyword>
</DOC>